
Ep. 372 - Biotech IPOs, Biosecure Act, cachexia pipeline
Jun 15, 2026 - 25:13
Radio and PodcastLive Radio & Podcasts
Revolution Medicines continues to impress with more pancreatic cancer data, earning a standing ovation at ASCO over the weekend. On the latest BioCentury This Week podcast, BioCentury’s analysts discuss the detailed data...
Ep. 369 - ASCO advances, China innovation & U.S. science under threat is an episode from BioCentury This Week by BioCentury. Revolution Medicines continues to impress with more pancreatic cancer data, earning a standing ovation at ASCO over...
This episode belongs to BioCentury This Week.
Use the player on this page to stream the episode online.
Published Jun 1, 2026, 39:13 long, audio available.